Patient recruitment starts for MERS vaccine trial
Inovio has begun recruitment for its collaborative vaccine study for Middle East Respiratory Syndrome (MERS). Inovio and GeneOne Life Science are co-developing Inovio’s MERS vaccine (GLS-5300) in partnership with the Walter Reed Army Institute of Research (WRAIR) in Maryland, where the trial is being conducted. Click on this link for more information.
